Tissue Regenix Group plc
Tissue Regenix Group plc, a pioneering name in regenerative medicine, is headquartered in the United Kingdom. Founded in 2006, the company has established itself as a leader in the development of innovative tissue regeneration technologies, primarily focusing on orthopaedics and wound care. With a strong presence in Europe and North America, Tissue Regenix offers unique products such as dCELL® technology, which decellularises human and animal tissues to create scaffolds that promote natural healing. This approach not only enhances patient outcomes but also addresses the growing demand for effective regenerative solutions. Recognised for its commitment to advancing medical science, Tissue Regenix has achieved significant milestones, positioning itself as a key player in the regenerative medicine industry. The company continues to drive innovation, making strides in both product development and market expansion.
DitchCarbon Score
How does Tissue Regenix Group plc's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Tissue Regenix Group plc's score of 23 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Tissue Regenix Group plc's reported carbon emissions
Tissue Regenix Group plc, headquartered in Great Britain, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Tissue Regenix may not have established formal commitments to reduce its carbon footprint or may not publicly disclose such information at this time. As the company operates within the regenerative medicine sector, it is essential for organisations in this industry to consider their environmental impact and adopt sustainable practices. Without specific emissions data or reduction initiatives, it remains unclear how Tissue Regenix is addressing climate change or contributing to broader sustainability goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Tissue Regenix Group plc is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
